BioSpace News Archive

Policy

FDA Roundup: March 17, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

March 17, 2023
·
5 min read
Drug Development

Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks Highlighted at the 2023 HAEi Regional Conference APAC

Pharvaris announced an oral presentation of positive data from its Phase 2 RAPIDe-1 study of PHVS416 for the on-demand treatment of attacks at the 2023 HAEi Regional Conference APAC, taking place in Bangkok, Thailand, on March 17-19, 2023.

March 17, 2023
·
7 min read
IRLAB to Hold Four Presentations at Scientific Congress AD/PD(TM) 2023

IRLAB Therapeutics AB announced that it will present new data in an oral presentation and hold three poster presentations at the International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, AD/PD ™ 2023, held on March 28- April 1, 2023, in Gothenburg, Sweden.

March 17, 2023
·
3 min read
Genetown

Biophytis Announces Ratio Change Under its American Depositary Receipt (“ADR”) Program

Biophytis SA annouces that it will change the ratio of its American Depositary Shares to Biophytis ordinary shares from one ADS representing 10 Shares, to one ADS representing 100 Shares.

March 17, 2023
·
4 min read
Lutris Pharma Presents Data From a Real-World Analysis of Skin Toxicity From EGFR Inhibitors - an Unmet Challenge, at the 2023 American Academy of Dermatology Annual Meeting

Lutris Pharma today announced the presentation of data from a real-world analysis of skin toxicity from EGFR inhibitors and the associated unmet challenge, in an e-poster at the 2023 American Academy of Dermatology (AAD) Annual Meeting being held March 17-21, in New Orleans, LA.

March 17, 2023
·
3 min read
Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK

Bruker announces that the United Kingdom is expanding its fundamental research infrastructure with recent orders for two .2 GHz Avance ™ nuclear magnetic resonance (NMR) spectrometers for the University of Warwick and the University of Birmingham.

March 17, 2023
·
3 min read
Business

Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update

Spectrum Pharmaceuticals, Inc. today announced it will host a conference call to discuss the fourth quarter and full year 2022 financial results and provide a corporate update on Wednesday, March 22, 2023, at 8:30 a.m. Eastern/5:30 a.m. Pacific.

March 17, 2023
·
3 min read
Business

Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion

Samsung Biologics, a leading contract development and manufacturing organization, announced that the company will commence the construction of a fifth plant as part of its strategic expansion in response to increased market demand.

March 17, 2023
·
3 min read
Business

Zevra Therapeutics Announces Collaboration with RARE-X and the Sleep Consortium as Founding Member of New Sleep Data Initiative

Zevra Therapeutics, Inc. today announced that it has joined the Sleep Data Initiative as a founding member.

March 17, 2023
·
6 min read
Business

Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023

Impel Pharmaceuticals Inc. today announced it will host a live webcast on Friday, March 24, 2023, at 8:30 a.m. ET to report its fourth quarter and full year 2022 financial results and provide a business update.

March 17, 2023
·
1 min read